The Molecular Mechanism of Resveratrol in the Treatment of Chronic Rhinosinusitis Through a Combination of Network Pharmacology and In Vitro Validation

被引：0
作者：
Cheng, Xiao [1 ]
Xu, Shanshan [1 ]
Han, Furong [1 ]
Song, Zhihui [1 ]
Wang, Jiawei [1 ]
机构：
[1] Capital Med Univ, Beijing Tongren Hosp, Dept Pharm, Beijing, Peoples R China
来源：
CHEMICAL BIOLOGY & DRUG DESIGN | 2025年 / 105卷 / 03期
关键词：
apoptosis; chronic rhinosinusitis; inflammatory response; network pharmacology; oxidative stress; resveratrol; APOPTOSIS; HYPOXIA; IDENTIFICATION; PROLIFERATION; ACTIVATION; DOCKING; PATHWAY; CDOCKER; CELLS;
D O I：
10.1111/cbdd.70057
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Resveratrol (RES) is a polyphenolic antioxidant derived from different plant products, which has anti-inflammatory and antioxidative stress effect. However, the effect of resveratrol on chronic rhinosinusitis (CRS) still lacks systematic research. This study aims to elucidate the potential mechanism of resveratrol against CRS disease through network pharmacology and further verify it through biological experiments in human nasal epithelial cells (HNEpCs). The potential targets and pathways of RES against CRS disease were predicted by network pharmacology and molecular docking. Furthermore, the inflammation of HNEpCs was induced by lipopolysaccharide (LPS). The method of ELISA was used to detect changes in inflammatory factors and oxidative stress-related factors. The RT-qPCR method was adopted to analyze the changes of genes in related signaling pathways. As a result, 33 potential targets related to the effect of RES against CRS disease were obtained. According to the results of network pharmacology, it was shown that the effect of RES against CRS disease was closely related to the inflammation, oxidative stress, and apoptosis. A variety of results from cell experiments verified that RES can effectively inhibit the inflammation, oxidative stress and apoptosis of LPS-induced HNEpCs. Together, the present study systematically clarified the possible mechanisms of RES in the treatment of CRS and provided new ideas for the drug research of this disease.
引用
收藏
页数：14
相关论文
共 54 条
  • [1] Almazan E., Belzberg M., Qin C.X., Et al., 494 Association of Granuloma Annulare With Type II Diabetes, Cigarette Smoking, and Liver Disease: A Case–Control Study, Journal of Investing, 140, 7, pp. 67-69, (2020)
  • [2] Annaji M., Poudel I., Boddu S.H.S., Et al., Resveratrol-Loaded Nanomedicines for Cancer Applications, Cancer Research, 4, 3, (2021)
  • [3] Arild Danielsen K., Eskeland O., Fridrich-Aas K., Cecilie Orszagh V., Bachmann-Harildstad G., Burum-Auensen E., Bacterial Biofilms in Chronic Rhinosinusitis, Distribution and Prevalence, Acta Oto-Laryngologica, 136, 1, pp. 109-112, (2016)
  • [4] Belmonte-Reche E., Penalver P., Caro-Moreno M., Et al., Silyl Resveratrol Derivatives as Potential Therapeutic Agents for Neurodegenerative and Neurological Diseases, European Journal of Medicinal Chemistry, 223, (2021)
  • [5] Broderick T.L., Rasool S., Li R., Et al., Neuroprotective Effects of Chronic Resveratrol Treatment and Exercise Training in the 3xTg-AD Mouse Model of Alzheimer's Disease, International Journal of Molecular Sciences, 21, 19, pp. 7337-7357, (2020)
  • [6] Bussi C., Peralta Ramos J.M., Arroyo D.S., Et al., Autophagy Down Regulates Pro-Inflammatory Mediators in BV2 Microglial Cells and Rescues Both LPS and Alpha-Synuclein Induced Neuronal Cell Death, Scientific Reports, 7, (2017)
  • [7] Cao M.M., Li H., Sun D.Q., Et al., Cancer Burden of Major Cancers in China:A Need for Sustainable Actions, Cancer Communications, 40, 5, pp. 205-210, (2020)
  • [8] Cheng X., Yang Y.L., Yang H., Wang Y.H., Du G.H., Kaempferol Alleviates LPS-Induced Neuroinflammation and BBB Dysfunction in Mice via Inhibiting HMGB1 Release and Down-Regulating TLR4/MyD88 Pathway, International Immunopharmacology, 56, pp. 29-35, (2018)
  • [9] Cho D.Y., Zhang S., Lazrak A., Et al., Resveratrol and Ivacaftor Are Additive G551D CFTR-Channel Potentiators: Therapeutic Implications for Cystic Fibrosis Sinus Disease, International Forum of Allergy & Rhinology, 9, 1, pp. 100-105, (2019)
  • [10] Copeland E., Leonard K., Carney R., Et al., Chronic Rhinosinusitis: Potential Role of Microbial Dysbiosis and Recommendations for Sampling Sites, Frontiers in Cellular and Infection Microbiology, 8, (2018)
123456